September 25, 2013
  • Largest Study Yet: Most Can Tolerate Statins Despite Initial Side Effects

    Statin intolerance isn’t forever for most patients. The largest study to date on the topic found that most patients could tolerate the drug class when rechallenged. Find out what the authors say about the effectiveness of intermittent dosing as an alternative. 

  • Acute Otitis Media Reduced With Recommended
    Vitamin D Levels

    Preventing and treating acute otitis media, especially when it reoccurs often in small children, is a challenge in pediatrics. Now, a new study suggests that supplementation can help reduce recurring acute otitis media in small children whose Vitamin D levels are too low. How much Vitamin D for how long was required to lower the risks?

  • Newly Approved Antimicrobials Cause More Adverse Events Than Reported

    Not all adverse events for recently approved antimicrobials are in the package inserts, according to a presentation at the recent Interscience Conference on Anti-Microbial Agents and Chemotherapy in Denver. Here’s what researchers found out when they reviewed the FDA Adverse Event Reporting System (AERS) database.

  • Legislative Response to Meningitis Outbreak Could Limit Community Pharmacies

    Pharmacists’ ability to compound medications for individual patients could be threatened by legislation seeking to prevent future outbreaks such as last year’s tragedy involving compounded methylprednisolone acetate injections and meningitis. One critical issue is whether community pharmacy oversight would be provided by the FDA or state pharmacy boards. The National Community Pharmacists Association has weighed in.

U.S. Pharmacist Social Connect